RECCE-327

N/A

Report date: 2024/12/26 15:57:15
NMEQIDP

Base Information

Drug NameRECCE-327
Drug Alias NameRECCE-327RECCE 327R-327R 327R-327G
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionMembrane proteins inhibitorsCell wall modulators
TargetsMembrane proteins
Therapy Area/IndicationsHospital-acquired pneumoniaDiabetic FootUrinary Tract Infections +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaIndonesia
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesRecce Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRecce Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsHospital-acquired pneumoniaDiabetic FootUrinary Tract Infections +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A